RI-002 ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
65	原発性免疫不全症候群	1

65. 原発性免疫不全症候群

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01814800 (ClinicalTrials.gov)	February 2014	6/3/2013	Pharmacokinetics, Efficacy, and Safety Study of RI-002(IGIV) in Subjects With Primary Immunodeficien ...	An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002(IG ...	Primary Immune Deficiency Disorder	Biological: RI-002	ADMA Biologics, Inc.	NULL	Completed	2 Years	75 Years	All	59	Phase 3	United States

First Previous1Next Last